Bristol-Myers Squibb Company PFD CONV 2
BMYMP · OTC
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Assets | – | – | – | – |
| Cash & Equivalents | $10 | $11 | $9 | $14 |
| Short-Term Investments | $1 | $1 | $0 | $3 |
| Receivables | $14 | $15 | $14 | $13 |
| Inventory | $3 | $3 | $2 | $2 |
| Other Curr. Assets | $2 | $2 | $2 | $1 |
| Total Curr. Assets | $30 | $32 | $27 | $33 |
| Property Plant & Equip (Net) | $8 | $8 | $7 | $7 |
| Goodwill | $22 | $21 | $21 | $21 |
| Intangibles | $24 | $27 | $36 | $43 |
| Long-Term Investments | $3 | $2 | $2 | $3 |
| Tax Assets | $4 | $3 | $1 | $1 |
| Other NC Assets | $2 | $1 | $1 | $2 |
| Total NC Assets | $63 | $63 | $70 | $76 |
| Other Assets | $0 | $0 | $0 | $0 |
| Total Assets | $93 | $95 | $97 | $109 |
| Liabilities | – | – | – | – |
| Payables | $4 | $3 | $3 | $3 |
| Short-Term Debt | $2 | $3 | $4 | $5 |
| Tax Payable | $2 | $1 | $1 | $1 |
| Deferred Revenue | $0 | $0 | $0 | $0 |
| Other Curr. Liab. | $15 | $13 | $12 | $11 |
| Total Curr. Liab. | $24 | $22 | $22 | $22 |
| LT Debt | $48 | $37 | $35 | $40 |
| Deferred Rev, NC | $0 | $0 | $0 | $0 |
| Deferred Tax Liab, NC | $0 | $0 | $2 | $5 |
| Other NC Liab. | $3 | $5 | $5 | $6 |
| Total NC Liab. | $52 | $43 | $44 | $51 |
| Other Liabilities | $0 | $0 | $0 | $0 |
| Cap. Leases | $2 | $2 | $1 | $1 |
| Total Liabilities | $76 | $66 | $66 | $73 |
| Equity | – | – | – | – |
| Pref Stock | $0 | $0 | $0 | $0 |
| Common Stock | $0 | $0 | $0 | $0 |
| Retained Earnings | $15 | $29 | $26 | $24 |
| AOCI | -$1 | -$2 | -$1 | -$1 |
| Other Equity | $0 | $0 | $0 | $0 |
| Total Equity | $16 | $29 | $31 | $36 |
| Supplemental Information | – | – | – | – |
| Minority Interest | $0 | $0 | $0 | $0 |
| Total Liab. & Tot. Equity | $93 | $95 | $97 | $109 |
| Net Debt | $39 | $28 | $30 | $31 |